|
DCTN6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08690000000244E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28619999995028E-06 |
| Normal-vs-Stage2 |
2.098400E-02 |
| Normal-vs-Stage3 |
3.095700E-02 |
| Normal-vs-Stage4 |
9.964800E-04 |
| Stage1-vs-Stage2 |
2.542000E-01 |
| Stage1-vs-Stage3 |
1.252840E-01 |
| Stage1-vs-Stage4 |
7.299600E-01 |
| Stage2-vs-Stage3 |
8.525600E-01 |
| Stage2-vs-Stage4 |
2.307400E-01 |
| Stage3-vs-Stage4 |
1.837560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03819999999855E-06 |
| Normal-vs-AfricanAmerican |
2.046200E-04 |
| Normal-vs-Asian |
8.810800E-04 |
| Caucasian-vs-AfricanAmerican |
9.724200E-01 |
| Caucasian-vs-Asian |
2.185400E-01 |
| AfricanAmerican-vs-Asian |
2.139800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67419999974605E-07 |
| Normal-vs-Female |
3.383700E-03 |
| Male-vs-Female |
1.099510E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.917780E-03 |
| Normal-vs-Extreme_Weight |
1.66779999999367E-06 |
| Normal-vs-Obese |
1.844080E-03 |
| Normal-vs-Extreme_Obese |
5.006200E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.298800E-01 |
| Normal_Weight-vs-Obese |
9.096200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.912000E-01 |
| Extreme_Weight-vs-Obese |
2.087400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.461400E-01 |
| Obese-vs-Extreme_Obese |
2.137800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.745200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.90230000000269E-05 |
| Normal-vs-Age(61-80Yrs) |
1.55639999999124E-06 |
| Normal-vs-Age(81-100Yrs) |
5.984100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.957000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.519200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.402400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.349790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.422600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.577200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.20249999641709E-08 |
| Normal-VS-Type2 PRCC |
9.160700E-04 |
| Normal-VS-KIRP CIMP |
1.839610E-01 |
| Normal-VS-Unclassified PRCC |
4.817500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.154100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.223420E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.567400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.601800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.584400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.140800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.567480E-04 |
| Normal-vs-N1 |
7.737200E-03 |
| Normal-vs-N2 |
1.938960E-01 |
| N0-vs-N1 |
7.932800E-01 |
| N0-vs-N2 |
6.128400E-01 |
| N1-vs-N2 |
7.491600E-01 |
|
|
